Skip to main content

A slow release insemination that doubles the success rate of the most common first line treatment of infertility.

Project description

Helping nature in a more natural way could boost fertility for millions

Infertility affects millions of couples globally. Aside from the emotional and physical toll that unsuccessful treatments and failure to conceive can have on couples, fertility treatments can come with a hefty price tag. This economic barrier can make access to treatment challenging for those with fewer financial resources. Intrauterine insemination (IUI) is simpler and less costly than in vitro fertilisation (IVF) but the success rates are much lower. The EU-funded EVIE 2.0 project is bringing its patented, FDA-approved IUI, EVIE, to market as an alternative to conventional IUI. Since EVIE more than doubles a patient's chance of success compared to standard IUI for patients under 35, storks could soon be on their way to millions of couples worldwide.

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Coordinator

FERTILIGENT LTD
Address
37 Hahashmonain St.
4325623 Ra Anana
Israel

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000